அல்சைமர் டெமென்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அல்சைமர் டெமென்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அல்சைமர் டெமென்ட் Today - Breaking & Trending Today

Frontiers | A Novel Probable Pathogenic PSEN2 Mutation p.Phe369Ser Associated With Early-Onset Alzheimer's Disease in a Chinese Han Family: A Case Report


Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
The pathogenesis of Alzheimer s disease is complex, and early-onset Alzheimer s disease (EOAD) is mostly influenced by genetic factors. Presenilin-1, presenilin-2 (PSEN2), and amyloid precursor protein are currently known as the three main causative genes for autosomal dominant EOAD, with the PSEN2 mutation being the rarest. In this study, we reported a 56-year-old Chinese Han proband who presented with prominent progressive amnesia, aphasia, executive function impairment, and depression 5 years ago. The 3-year follow-up showed that the patient experienced progressive brain atrophy displayed on magnetic resonance imaging (MRI) and dramatic cognitive decline assessed by neuropsychological evaluation. This patient was clinically diagnosed as EOAD based on established criteria. A heterozygous variant (NM 000447.2: c.1106T>C) of PSEN2 was identified for the first time in this patient a ....

United Kingdom , United States , San Diego , Ultrasonicator Covaris , Silva Lopes , Alzheimers Dement , User Tax , National Natural Science Foundation Of China , Department Of Neurology , Sequence Control Software Illumina , Key Research , Development Projects Of Anhui Province , National Institute On , Xgen Exome Research Panel , Mathworks Inc , Exome Aggregation Consortium Ex , Montreal Neurological Institute , Alzheimer Association , Chinese Han , First Affiliated Hospital , Anhui Medical University , Ethics Committee , Computational Anatomy Toolbox , Mini Mental State Examination , Montreal Cognitive Assessment , Cambridge Cognitive Examination Chinese ,

Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer's Disease, Insomnia and Epilepsy


Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer s Disease, Insomnia and Epilepsy
Twenty-one presentations featuring data and information on investigational lecanemab in early Alzheimer s disease, DAYVIGO® (lemborexant) CIV in insomnia, FYCOMPA® (perampanel) CIII in epilepsy and investigational lorcaserin in Dravet Syndrome
News provided by
Share this article
Share this article
WOODCLIFF LAKE, N.J., April 16, 2021 /PRNewswire/ Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that data from the company s deep neurology pipeline and portfolio, including Alzheimer s disease, insomnia and epilepsy, will be presented at the 73
rd Annual Meeting of the American Academy of Neurology (AAN), taking place virtually from April 17-22, 2021. ....

United States , New Jersey , North Carolina , Gary Zammit , Shau Yu Lynch , Alzheimers Dement , Ryan Husni , Genevieve Meier , Carmen Castrillo Viguera , Craig Chepke , Ivan Cheung , Chris Vancheri , Michael Irizarry , Russell Rosenberg , Rakeh Jain , Rohit Shankar , National Institute On , Biogen Inc , Prnewswire Eisai Inc , European Union , Us Drug Enforcement Administration , Eisai Tsukuba Research Laboratories , Meeting Of The American Academy Neurology , National Institutes Of Health , Epilepsy Foundation , Drug Administration ,